Clinical data | |
---|---|
Trade names | Fungizone, Mysteclin-F, others |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration |
usually I.V. (slow infusion only) |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 100% (IV) |
Metabolism | kidney |
Biological half-life | initial phase : 24 hours, second phase : approx. 15 days |
Excretion | 40% found in urine after single cumulated over several days biliar excretion also important |
Identifiers | |
|
|
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
KEGG | |
ChEBI | |
ChEMBL | |
NIAID ChemDB | |
ECHA InfoCard | 100.014.311 |
Chemical and physical data | |
Formula | C47H73NO17 |
Molar mass | 924.091 |
3D model (Jmol) | |
Melting point | 170 °C (338 °F) |
|
|
|
|
Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include aspergillosis, blastomycosis, candida, coccidioidomycosis, and . For certain infections it is given with flucytosine. It is typically given by injection into a vein
Common side effects include a reaction with fever, chills, and headaches soon after the medication is given, as well as kidney problems. Allergic symptoms including anaphylaxis may occur. Other serious side effects include low blood potassium and inflammation of the heart. It appears to be relatively safe in pregnancy. There is a lipid formulation that has a lower risk of side effects. It is in the polyene class of medications and works in part by interfering with the cell membrane of the fungus.
Amphotericin B was originally made from Streptomyces nodosus in 1955. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. It is available as a generic medication. The cost in the developing world of a course of treatment as of 2010 is between 162 and 229 USD.